Impact of COVID-19 infection on laboratory and clinical outcomes of ovarian stimulation using antagonist protocol
Our data revealed that increased available and high-quality embryo rates seen in the non-infection group during second COS cycle were not observed in infected patients. Nonetheless, when comparing intra-individual, no detrimental effects on laboratory or clinical outcomes were found. This indicates that while COVID-19 appears to compromise the advantages of a repeat cycle, it does not worsen ovarian function.
Authors
- X.Y. Chen (ORCID: https://orcid.org/0000-0001-8233-8504)
- Wen Li (ORCID: https://orcid.org/0000-0002-6722-0804)
- Qing Zhang (ORCID: https://orcid.org/0000-0001-8479-399X)
- Li Wang (ORCID: https://orcid.org/0000-0002-2929-4255)
- Meiling Zhang (ORCID: https://orcid.org/0000-0002-8882-2564)
- Min Wang (ORCID: https://orcid.org/0000-0003-0841-2651)
- Mengxi Guo (ORCID: https://orcid.org/0009-0007-9490-6661)
- Tao Yu (ORCID: https://orcid.org/0000-0003-4939-8956)
- Yan Yu
Institutions
- International Peace Maternity & Child Health Hospital (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-12-19
- DOI
- https://doi.org/10.3389/fmed.2025.1674189
- Primary Topic
- COVID-19 Impact on Reproduction
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Shanghai
- National Natural Science Foundation of China
- Shanghai Jiao Tong University
- Shanghai Hospital Development Center
- National Key Research and Development Program of China